Patent · US Active

Forms of apremilast

US10196355B2 · kind B2 · utility

1Cited by
6References
10Claims
0Family size

Assignee

Inventor

Key dates

Filing dateJun 20, 2016
Grant dateFeb 5, 2019
Priority date
Expiry dateJun 20, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present disclosure is directed to novel forms of apremilast and pharmaceutical compositions comprising any of the novel forms of apremilast. Also provided are processes for the preparation of novel forms of apremilast.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.